Zealand Pharma A/S at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham and Company. It's my pleasure to introduce our next presenting company, Zealand Pharma.
Joining us today from Zealand is CEO Adam Steensberg. Following the presentation, we'll have a brief Q&A session. (Conference Instructions)
So with that, we'll get started. I'll turn it over to Adam for the presentation.
/-
Thanks, Joey, and thanks for participating in this virtual call, all of you guys. So it's really a pleasure for me today to present Zealand Pharma. So we are a Danish-based company who have been working with peptide drug discovery and development for 25 years now. So our headquarters is in Denmark, but we also have employees in the US, so we consider ourselves an international company.
I will be making forward-looking statements today, as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |